Literature DB >> 3173514

[Cholestatic hepatitis caused by a combination of amoxicillin and clavulanic acid (Augmentin)].

J W van den Broek, B L Buennemeyer, B H Stricker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3173514

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


× No keyword cloud information.
  6 in total

1.  Hepatitis and augmentin.

Authors:  K R Reddy; E R Schiff
Journal:  Dig Dis Sci       Date:  1990-08       Impact factor: 3.199

2.  Population Scale Retrospective Analysis Reveals Potential Risk of Cholestasis in Pregnant Women Taking Omeprazole, Lansoprazole, and Amoxicillin.

Authors:  Yonghong Zhang; Da Shi; Ruben Abagyan; Weina Dai; Mingyang Dong
Journal:  Interdiscip Sci       Date:  2019-05-20       Impact factor: 2.233

Review 3.  Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

4.  Co-amoxiclav jaundice: clinical and histological features and HLA class II association.

Authors:  J O'Donohue; K A Oien; P Donaldson; J Underhill; M Clare; R N MacSween; P R Mills
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

5.  Cholestatic hepatitis due to antibacterial combination of amoxicillin and clavulanic acid (augmentin)

Authors:  B H Stricker; J W Van den Broek; J Keuning; W Eberhardt; H G Houben; M Johnson; A P Blok
Journal:  Dig Dis Sci       Date:  1989-10       Impact factor: 3.199

6.  An Uncommon Side Effect of a Commonly Used Antibiotic: Amoxicillin-Clavulanic Acid Induced Hepatitis.

Authors:  Vinay Mathew Thomas; Neena Thomas-Eapen
Journal:  Korean J Fam Med       Date:  2017-09-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.